ArtVentive Medical Group (OTC:AVTD) announced plans to launch its EOS peripheral vascular endoluminal occlusion system in the European Union following CE Mark approval for the self-expanding catheter device.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Online insurance marketplaces face challenges
MASSDEVICE ON CALL — New insurance marketplace exchanges are a major policy platform of the Affordable Care Act, but some experts fear technical difficulties as the deadline rapidly approaches this October, according to The Wall Street Journal.
The tech experts building the government exchange websites warned customer to expect glitches when the system first goes live, the newspaper said.
Edwards Lifesciences’ Perimount heart valve fares well in 25-year study
The Perimount aortic valve implant made by Edwards Lifesciences (NYSE:EW) lasts about 17 years post-implantation, according to 25-year data from a study of the valve in patients younger than 60.
Survey: Most companies aren’t ready to implement healthcare reform | MassDevice.com On Call
MASSDEVICE ON CALL — The vast majority of U.S. companies consider rising healthcare costs a "top concern" moving forward, and more than half are under-prepared to implement programs required by new laws.
More than 80% of the companies surveyed named healthcare among the top budgetary concerns, up from the 74% in the last iteration of the study.
Sign up to get our free newsletters delivered straight to your inbox
[sead]
Abbott kicks off a Japanese trial for its “dissolving” vascular scaffold
J&J’s Cordis lands FDA win for next-gen Adroit guiding catheter
Cordis Corp., the stent-making division of Johnson & Johnson (NYSE:JNJ), landed a new U.S. regulatory win for its next-generation Adroit 6F Guiding Catheter, which the company said can handle more sophisticated cases than earlier versions.
Medtronic notches small win in German TAVI war with Edwards Lifesciences
How to simplify consents
Kentucky cardiologist confesses to unnecessary stenting
Kentucky-based cardiologist Dr. Sandesh Rajaram Patil, 51, admitted this week that he lied about a patient’s heart health in order to justify implanting a stent and submitting a claim for federal reimbursement. Patil is the 3rd cardiologist nationwide and the 1st from Kentucky to face federal prosecution for unnecessary cardiac stenting.
Cook Medical lands FDA win for Evolution biliary gastrointestinal stent
Medical device maker Cook Medical won FDA clearance for its Evolution biliary stent, the latest in the company’s line of controlled-release stents designed for use in the gastrointestinal tract.
Like the rest of the Evolution line, the newly cleared biliary stent delivery system includes recapture technology that allows physicians to modify the stent’s placement before full deployment.
States questioned for selling patient records, risking privacy | MassDevice.com On Call
MASSDEVICE ON CALL — Health records from hospitals in 26 states that was later sold to researchers and companies contained data that could be linked to individuals, raising concerns about how differing levels of compliance with data redaction standards put patients’ privacy at risk, Bloomberg reported.